Healthcare company Magnolia Medical Technologies recently revealed promising results from an in-vitro study demonstrating that the Steripath® Initial Specimen Diversion Device® (ISDD®) could significantly enhance the accuracy of blood cultures drawn from existing central venous catheters (CVCs). This innovation may change the landscape of infection detection, particularly for severely ill patients dependent on CVCs.
The investigators…